Thin
Custom Setmelanotide CAS 920014-72-8 from China Suppliers and Factory for Genetic Obesity Treatment Manufacturers, Quotes
Get Specifications & Quote
Explore high-demand therapeutic peptides, incretin GLP-1/glucagon dual agonists, and regulatory compliant bulk APIs available for swift international sampling and validation.
An in-depth perspective on metabolic biology, increasing regulatory stringency, and why precision chemical synthesis is superseding legacy recombinant production.
The worldwide peptide therapeutic segment is expanding at unprecedented compound annual growth rates, propelled by GLP-1, GLP-2, dual GIP/GLP agonists, and amylin analogues. Molecules like Semaglutide, Tirzepatide, Survodutide, and Cargrilintide demand multi-ton annual capacity to satiate chronic metabolic, T2D, and NASH management pipelines globally.
Regulatory scrutiny regarding related peptide impurities, immunogenicity profiles, and enantiomeric purity has escalated. Modern procurement is not merely buying weight; it requires complete diastereomer separation, strict D-amino acid thresholds (<0.1%), and transparent host-free synthetic pathways to avert anti-drug antibody formation.
While recombinant fermentation was historically leveraged for 30+ residue peptides, advancements in High-Throughput Solid-Phase Peptide Synthesis (SPPS) paired with Liquid-Phase fragment condensation have made chemical synthesis substantially more cost-effective, free from host cell protein (HCP) contaminants, and easily scalable.
From Hangzhou’s Heda Medicine Valley to the worldwide pharmaceutical supply chain, our fully vertically integrated ecosystem bridges upstream resin/amino acid synthesis directly to GMP purification.
We do not outsource raw materials. Hangzhou Thinheal maintains direct control over specialized protected amino acids (Fmoc/Boc chemistry), custom linkers, functionalized Wang or CTC resins, and coupling reagents (HATU, PyBOP). This self-contained supply chain buffers against global price spikes and eradicates production delays.
Purification constitutes up to 60% of peptide production overhead. Utilizing proprietary continuous preparative HPLC systems with 300mm to 600mm dynamic axial compression (DAC) columns, we achieve exceptional single-run recoveries, dramatically cutting solvent consumption and delivering ultra-pure batches at fraction of Western facility costs.
Our process chemists optimize synthesis routes directly at the milligram scale with full view toward metric ton campaigns. The translation from sequence validation to kilogram pilot lots occurs in weeks rather than quarters, saving clinical-stage biotechnology developers valuable runway and patent lifecycle time.
Different indications mandate discrete salt forms, counter-ion selections, and stability profiles. We formulate peptide bulk materials customized for exact downstream processing.
For chronic formulations requiring sustained bioavailability (such as Triptorelin depot or Vasopressin emergency therapeutics), we guarantee ultra-low endotoxin thresholds (<5 EU/mg) and precise acetate conversion to eliminate local injection site irritation and ensure physiological tolerance.
Targeting gastrointestinal receptors via Linaclotide or Teduglutide demands precise disulfide bond pairing (e.g., Linaclotide’s 3 intricate intramolecular bridges). Our catalytic oxidation strategies guarantee 100% correct folding, maximizing luminal stability against proteolytic degradation.
From signal hexapeptides to palmitoylated lipopeptides, stability in aqueous emulsions and transdermal penetration are critical. We supply lyophilized, uniform cosmetic peptide grades featuring verified bulk stability across varying temperature and pH vectors.
Review our baseline technical indicators, molecular designations, and wholesale order tiering. Final commercial pricing varies based on counter-ion requirements, regulatory filing tiers (DMF support), and volume agreements.
| Peptide API / Molecule | CAS Number | Sequence Length / Characteristic | Standard HPLC Purity | Primary Indication | Commercial Pricing Tier |
|---|---|---|---|---|---|
| Setmelanotide Acetate | 920014-72-8 | Cyclic 8-mer Peptide | ≥ 98.5% | Genetic Obesity (MC4R) | Tier 1: Clinical / Kg Base |
| Survodutide | 2805997-46-8 | 29-mer Glucagon/GLP-1 Agonist | ≥ 98.0% | NASH / Obesity Care | Tier 1: High Demand |
| Thymalin | 63958-90-7 | Synthetic Dipeptide Derivative | ≥ 99.0% | Immunomodulation | Tier 3: Bulk Multi-Kg |
| Vasopressin (ADH) | 50-57-7 | 9-mer Nonapeptide with Disulfide | ≥ 98.5% | Hemodynamic Support | Tier 2: Commercial API |
| Thymosin β4 Acetate (TB500) | 77591-33-4 | 43-mer Complex Synthetic Chain | ≥ 98.0% | Tissue Regeneration | Tier 2: Research & Commercial |
| Cargrilintide | 1415456-99-3 | Long-Acting Amylin Analogue | ≥ 98.0% | Metabolic Combination | Tier 1: Custom CDMO |
| Tesamorelin | 218949-48-5 | 44-mer GHRH Analogue + Hexenoyl | ≥ 98.5% | Lipodystrophy Management | Tier 1: High Technical Barrier |
| Linaclotide | 851199-59-2 | 14-mer with 3 Disulfide Bridges | ≥ 98.5% | IBS-C / Chronic Constipation | Tier 2: Generic Dossier Ready |
Note: All pricing agreements are finalized under bilateral technical confidentiality. Detailed quotes are generated upon confirmation of annual volume, batch size, target salt profile (Acetate, TFA, or Hydrochloride), and packaging format.
How Hangzhou Thinheal Pharma-Tech guarantees chemical integrity, absence of truncation fragments, and dependable batch-to-batch consistency.
We determine overall purity using dual orthogonal RP-HPLC columns (C18 and phenyl-hexyl stationary phases). Reports illustrate all related substances, including deamidation, sulfoxidation, and beta-aspartyl shift forms.
High-resolution electrospray ionization mass spectrometry verifies parent ion mass along with multiple ionization states, confirming sequence accuracy and eliminating unintended deletion or double-insertion impurities.
Lyophilized cakes inherently contain moisture and counter-ions. Through rigorous amino acid analysis (AAA), we determine absolute net peptide content (typically 80–90%), enabling exact pharmaceutical dosage formulations.
SPPS entails DMF, DCM, piperidine, and acetonitrile. Our gas chromatography head-space analysis ensures volatile organic compounds comply rigorously with ICH Q3C limits for pharmaceutical substances.
Utilizing kinetic turbidimetric or chromogenic LAL assays in Class C/D cleanroom environments, we guarantee endotoxin-free powders necessary for sterile injectable manufacturing and parenteral filings.
Peptides are lyophilized in specialized amber borosilicate vials with inert argon headspace. Shipments across North America, Europe, and Asia utilize monitored cold-chain dry ice packing to protect structural folding.
Explore additional specialized peptides in our inventory, featuring sustained-release GnRH agonists, bowel rehabilitation analogues, nootropic modulators, and metabolic regulators.
Mitigating geopolitical, technical, and regulatory risks when establishing commercial peptide API procurement channels.
Enterprise buyers initiate procurement with analytical pilot evaluation (10g–50g) to confirm orthogonal HPLC match, diastereomer baseline, and MS fragmentation before progressing to process verification lots (100g–500g) and multikilogram commercial contracts. Hangzhou Thinheal supports every transition step with comprehensive Certificate of Analysis (CoA) validation.
Navigating NMPA, US-FDA, and EMA regulatory frameworks requires detailed Drug Master File (DMF) packages. We supply prospective generic filers with full Open DMF segments, containing synthesis route clarification, potential genotoxic impurity risk assessments, residual solvent clearances, and accelerated stability trending.
Cross-border customs clearance of pharmaceutical actives requires experienced export compliance. Our dedicated trade desks—spanning North America & Europe, Russia & CIS, Asia, and Middle East—facilitate smooth customs entry, correct Harmonized Tariff Schedule (HTS) coding, and end-to-end monitored temperature data loggers.
Clear, expert responses to the questions most frequently raised by international sourcing directors, formulation scientists, and QA auditors.